Dopamine-β-hydroxylase activity in cholinergic neuroblastoma × glioma hybrid cells; increase of activity by N6,O2′-dibutyryl adenosine 3′: 5′-cyclic monophosphate  by Hamprecht, Bernd et al.
Volume 42, number 2 FEBS LE'ITERS June 1974 
DOPAMINE-f l -HYDROXYLASE ACTIV ITY IN CHOLINERGIC NEUROBLASTOMA 
5< GLIOMA HYBRID CELLS; INCREASE OF ACTIVITY BY N6,O 2 '- 
D IBUTYRYL  ADENOSINE 3': 5'-CYCLIC MONOPHOSPHATE 
Bernd HAMPRECHT and J6rg TRABER 
Max-Planck-Institut ffir lh'ochemie, 8033 Martinsried, Germany 
and 
Friedhelm LAMPRECHT 
Laboratory of Clinical Science, National Institute of Mental Health, 
Bethesda, Maryland 20014, USA 
Received 9 March 1974 
1. Introduction 
The last step in the biosynthesis of noradrenaline, 
the hydroxylation of dopamine, is catalized by the 
enzyme dopomine-~-hydroxylase (DBH, EC 1.14.2.1) 
[1]. As this enzyme is found only in adrenal glands 
and adrenergic nerves [2,3], it can serve as a marker 
for adrenergic neurons. The enzyme was also detected 
in neuroblastoma C 1300, a spontaneous tumor of 
the region of spinal cord of a mouse, and in clonal 
cell lines derived from it [4]. In hybrids between 
mouse neuroblastoma and rat glioma cells [5] dense 
core vesicles are observed [6]. They resemble those 
seen in adrenal medulla [7] or adrenergic nerves [8], 
which contain catecholamines [9,10] and DBH 
[11-13]. Therefore, it was tempting to assume that 
DBH and catecholamines were also present in the 
neuroblastoma X glioma hybrid ceils. 
In this communication we should like to report 
that DBH is found in 2 neuroblastoma X glioma 
hybrid cell lines and in the parental neuroblastoma 
cell line, but cannot be detected inthe parental glioma 
line. The specific activity of DBH is much higher in 
the hybrid cells than in the neuroblastoma line. The 
hybrid cells also show high specific activities of 
choline acetyltransferase, theenzyme catalizing the 
biosynthesis of the neurotransmitter acetylcholine 
[5], and contain clear vesicles, which are a character- 
istic of cholinergic neurons [6]. Thus the cells 
simultaneously have characteristics of both cholinergic 
and adrenergic neurons. In the presence of N6,O 2'- 
dibutyryl adenosine 3': 5'-cyclic AMP (dibutyryl 
cyclic AMP) the hybrid cells send out long processes. 
The specific DBH activity of one hybrid clone 
increases several fold above the control values when 
the cells are grown in the presence of this compound. 
Neither tyrosine hydroxylase (EC 1.14.3.a) [14], 
the enzyme catalizing the first step in the pathway 
from tyrosine to noradrenaline, nor dopamine or 
noradrenaline can be detected in the parental and the 
hybrid cell lines. 
2. Materials and methods 
2.1. Cell culture 
The neuroblastoma cell line N18TG2 is a 
6-thioguanine r sistant mutant [15] of a clonal ine 
derived from mouse neuroblastoma C-1300 [16]. 
The line C6-BU-1 is a bromodeoxyuridine resistant 
mutant [17] of clonal ine C6 derived from a 
chemically induced tumor of a rat embryo [18]. 
Hybrids between lines N 18TG2 and C6-BU-1 were 
prepared by fusion in the presence of inactivated 
Sendai virus as will be described elsewhere [5]. The 
two hybrid clones mentioned in this paper have the 
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laboratory designations 108CC5 and 108CC15. The 
cells weie grown at 37°C in Falcon plastic flasks 
(75 cm =) or plastic dishes (diameter 100 mm) as 
described [19]. The growth medium for N18TG2 
was supplemented with 0.1 mM 6-thioguanine (Sigma), 
that for C6-BU-1 with 0.1 mM bromodeoxyuridine 
(Sigma) and that for the hybrid clones with 0.1 mM 
hypoxanthine (Sigma), 10/aM aminopterine (Nutri- 
tional Biochemical Corp.) and 0.16 mM thymidine 
(Sigma). In the cases indicated the medium contained 
4 mM dibutyryl cyclic AMP (Sigma). The cells were 
subcultured by brief exposure to 0.05% trypsin [20]. 
They were counted in a hemocytometer and their 
viability was determined by exclusion of nigrosin. 
2.2. Assays 
After removal of the growth medium, the cells 
were washed twice with ice-cold medium D2 [21 ]
adjusted to 340 mOsmols [20]. After draining of the 
plates at an angle of approximately 45degrees for 
1 min, the cells were scraped off using ice-cold 0.05 M 
Tris-HC1 buffer, pH 6.0, containing 0.2% Triton 
X-100. The cell suspensions were homogenized by 
sonication, the homogenates divided into several 
aliquots and stored over liquid nitrogen. A separate 
aliquot was thawed immediately before each assay 
and kept in ice. Tyrosine hydroxylase [22], DBH 
[23], dopamine and noradrenaline [24] were deter- 
mined as described. Protein was assayed using bovine 
serum albumin as standard [25]. 
3. Results 
On treatment with dibutyryl cyclic AMP for more 
than 8 days neuroblastoma X glioma hybrid clones 
extend long processes (fig. 1). Similarly, this com- 
pound induces formation of processes in glioma line 
C6-BU-1, though already within 24 hours [26]. When 
treated this way for several days the neuroblastoma 
Fig. la. (Legend under lc.) 
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Fig. lb. (Legend 
cells N 18TG2 form comparatively short processes. 
The activity of DBH found is strongly dependent 
on the concentration f Cu 2 + ions in the assay system 
[27]. Therefore, in order to determine the maximal 
activity of the enzyme, assays were performed at 
varying concentrations of the metal ion. Fig. 2 shows 
that the optimal concentration f cupric ions added 
to the assay mixture is lower for cells treated with 
dibutyryl cyclic AMP than for untreated cells. 
Neuroblastoma clone N18TG2 requires the addition 
of much higher concentrations of Cu 2 ÷ ions than the 
hybrid clones. The reason for these differences could 
be variations of cellular levels of free Cu ~ ÷ ions or of 
DBH inhibitors [27-30]. 
Irrespective of the maintenance in presence or 
absence of dibutyryl cyclic AMP, DBH activity can- 
not be detected in'glioma line C6-BU-1 (table 1). In 
contrast, neuroblastoma line N18TG2 and both 
hybrid clones contain DBH activity. Comparing cells 
not treated with dibutyryl cyclic AMP, the specific 
under 1 c.) 
activities of DBH are 3-5  times higher in the hybrids 
than in the parental neuroblastoma cells. On growth 
in the presence of dibutyryl cyclic AMP, specific 
activities of DBH are reduced by 75% in the 
neuroblastoma cells, remain constant in hybrid clone 
108CC5 and increase by a factor of 3 in hybrid clone 
108CC15 (table 1). 
None of the cell lines tested (see table 1) contained 
tyrosine hydroxylase activity and, consistently, 
neither dopamine nor noradrenaline could be detected. 
4. Discussion 
The extension of processes in response to dibu- 
tyryl cyclic AMP has been reported for clonal ines of 
neuroblastoma [31] and glioma cells [26]. The 
processes of the neuroblastoma X glioma hybrids 
(fig. 1) are much thicker (up to 10 ~u) and longer (up 
to 0.5 mm) than those reported for neuroblastoma 
cells [31 ]. 
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Fig. 1. Morphology.of neuroblastoma X glioma hybrid clone 108CC5. (a) Cells grown in the absence of dibutyryl cyclic AMP. 
B, C. Two examples of cells treated with dibutyryl cyclic AMP. Cells were seeded, 2 × 104 (b) and 5 × 104 (c), respectively, per 
60 mm plate, and 3 (B) and 4 (C) days later, respectively, the medium was replaced by the same medium supplemented with 
4 mM (B) and 1 mM (C) dibutyryl cyclic AMP, respectively. The photomicrographs were taken 11 and 16 days, respectively, 
after the onset of the treatment with d~utyryl cyclic AMP. The black bar represents 100 vm in A-C. Note the binary branching 
of the processes in C. 
It is consistent with the view of  DBH as a marker 
of adrenergic neurons that the enzyme could not be 
detected in glioma cells, even not in those stimulated 
to extend processes. The specific activity of DBH in 
the mutant neuroblastoma line N18TG2 is compara- 
ble to that reported for the wild type line N18 [4]. 
t~o e activity of choline acetyltransferase in N18TG2, 
ugh low, is well above the borderline of  detect- 
ability [32]. In addition to DBH activity, N18TG2 
cells contain dense core vesicles [6], a characteristic 
of adrenergic neurons that has already previously 
been observed with neuroblastoma cells [33]. How- 
ever, as dense core vesicles are occasionally observed 
even in cholinergic nerve endings [34], their presence 
is not sufficient o characterize a cell as adrenergic. 
It is the simultaneous presence of DBH and dense 
core vesicles that justifies talking about adrenergic 
properties. Although it has not been firmly established 
by hJstochemical or immunohistochemical procedures 
that choline acetyltransferase and DBH are present 
in the same cell, the possibility of a mixture of 2 cell 
populations i unlikely, since clonal cell lines were 
used. Thus, N18TG2 is a cell line which simultaneously 
displays proper ties of cholinergic and adrenergic 
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neurons. The presence of cholinergic and adrenergic 
properties in the same cell is even much more striking 
in the glioma X neuroblastoma hybrid cells. These  
cells have high activities of choline acetyl transferase 
[5,32] and clear vesicles [6] as characteristics of 
cholinergic neurons, and DBH activities and dense 
core vesicles as characteristics of adrenergic neurons. 
However, the set of adrenergic properties is incom- 
plete. Tyrosine hydroxylase, the first enzyme in the 
pathway of noradrenaline synthesis, is missing and, 
consequently, dopamine and noradrenaline ar not 
being synthesized from tyrosine. As the cell homo- 
genates were not assayed for the presence ofdihydroxy- 
phenylalanine d carboxylase, it is not known, 
whether or not the second enzyme of the pathway 
is also missing in the neuroblastoma and hybrid cells. 
To our knowledge these results how for the first 
time clearly the presence of cholinergic and adrenergic 
Fig. 2. Relationship between the concentration of Cu 2÷ ions 
added to the assay mixture and DBH activity for neuro- 
blastoma nd hybrid cell lines. Open symbols, cells not 
treated; closed symbols, cells treated with 4 mM dibutyryl 
cyclic AMP. Circles: neuroblastoma N18TG2; triangles and 
squares: hybrid clones 108CC5 and 108CC15, respectively. 
Table 1 
Specific activity ofDBH in neuroblastoma x glioma hybrids and their parent cells in absence 
and presence of dibutyryl cyclic AMP 
Cell fine Time of Total Number of viable cells Viability Optimal 
treatrn.* time of (X 10-6) at harvest concentr. 




(pmoles .min -1 
mg protein-1 ) 
Neuroblastoma 0 5 4.8 50 86.3 167 140 
N18TG2 4 13 0.024 2.8 96.4 83 37 
Glioma 0 6 0.99 48 98.7 - 0 
C6-BU-1 11 19 0.145 4.8 92.7 - 0 
Hybrid 0 7 0.06 4.3 92.3 33 450 
108CC5 10 13 0.048 0.060 85.7 3 510 
Hybrid 0 7 0.028 3.7 90.8 17 650 
108CC15 10 13 0.051 0.11 65.9 3 2070 
* Treatment with 4 mM dibutyryl cyclic AMP. 
The cells were grown in 100 mm dishes containing 20 ml of medium, except clonal line N18TG2 (absence of 
dibutyryl cyclic AMP), which was cultured in flasks (75 cm2). The media were renewed every 1 to 4 days as 
required to prevent the media from becoming acidic. 
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markers in the same cell. They suggest that it might 
principally be possible to have genes expressed in the 
same cell which are coding for proteins of more than 
one neurotransmitter system (comprising~biosynthesis, 
storage, release, re-uptake tc. of a neurotransmitter). 
In addition, the results demonstrate hat not all genes 
of a given neurotransmitter system (e.g. the adrenergic 
system) must necessarily be expressed simultaneously. 
It remains to be established whether this is true only 
for the aneuploid cells used in this study or whether 
it holds true also for the euploid cells of nervous 
tissue. 
As DBH was shown to be present in the dense 
core vesicles of adrenergic tissue [11-13,35,36],  it 
is tempting to predict hat this is also the case in the 
neuroblastoma and the hybrid cells. In the hybrid 
cells the formation of processes and the activity of 
DBH are regulated. Although dibutyryl cyclic AMP 
causes cells of both hybrid clones to extend large 
processes, it elevates the DBH activity in only one 
of them. This means that in the hybrid cells the 
extension of processes is not necessarily coupled 
with the increase in DBH activity. 
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